Sex­u­al ha­rass­ment in biotech hits home as Or­biMed’s Sam Isaly steps down in wake of STAT re­port

Two days af­ter Or­biMed gen­er­al man­ag­er Sam Isaly was hit by a scathing take­down by STAT writer Dami­an Garde out­lin­ing the fi­nancier’s pref­er­ences for on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.